Chromatographic determination of sulfasalazine and its active metabolites: greenness assessment and application to spiked human plasma

Green TLC-densitometric and RP-HPLC methods were developed and validated for the determination of the active prodrug sulfasalazine (SZ), its active metabolite mesalazine (MZ) and the major active metabolite of mesalazine, N-acetyl-5-aminosalicylic acid (AS). In the developed TLC-densitometric method, chromatographic separation was carried out on TLC silica gel plates 60 F₂₅₄ using a developing system consisting of ethyl acetate–methanol–ammonia solution 33% (8:2.5:0.3, by volume) and then scanning the separated bands at 215 nm using hydrochlorothiazide as an internal standard with linearity ranges of 0.4–3, 0.4–2.4 and 0.3–2 for SZ, MZ and AS, respectively. The developed RP-HPLC method depended on chromatographic separation using a C₁₈ column with a solvent mixture of methanol–aqueous acetic acid solution (pH 5) as a mobile phase with gradient elution mode and UV scanning at 243 nm using pyrazinamide as internal standard with linearity ranges of 5–50, 5–40, and 3–20 for SZ, MZ and AS, respectively. US Food and Drug Administration guidelines were followed during validation of the methods. The greenness of the developed methods was estimated using the greenness profile and the Eco-Scale approach. Both methods passed the four quadrants of the greenness profile and had Eco-Scale score ˃75, thus they were considered to be green according to these approaches.     

The metabolites and biotransformation pathways in vivo after oral administration of ocotillol,RT5, and PF11

Ocotillol, pseudo-ginsenoside RT5 (RT₅), and pseudo-ginsenoside F₁₁ (PF₁₁) are ocotillol-type saponins that have the same aglycone structure but with different numbers of glucose at the C-6 position. In this study, the metabolites of ocotillol, RT₅, and PF₁₁ in rat plasma, stomach, intestine, urine, and feces after oral administration were investigated by ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry. The results showed that RT₅ was easily biotransformed into metabolites in vivo, whereas PF₁₁ and RT₅ were difficult to be biotransformed. Hydrogenation, dehydrogenation, dehydration, deglycosylation, deoxygenation, hydration, phosphorylation, deoxidation, glucuronidation, and reactions combining amino acid were speculated to be involved in the biotransformation of ocotillol, RT₅, and PF₁₁. Based on the structural analysis of metabolites, it was deduced that hydrogenation, dehydration, deoxidation, and reactions combining amino acid occurred on the aglycone structure, whereas deglycosylation, hydration, and phosphorylation occurred on the glycosyl chain. Further, metabolites in plasma, urine, feces, and tissues were different: First, glucuronidation products were found in urine, stomach, intestine, and feces, but not in plasma. Second, the ocotillol prototype was not identified in urine samples. Third, the RT₅ prototype was found in stomach, intestine, feces, and urine, but not in plasma.     

A rapid and sensitive bioanalytical LC–MS/MS method for the quantitation of a novel CDK5 inhibitor 20–223 (CP668863) in plasma: Application to in vitro metabolism and plasma protein-binding studies

A rapid, selective, and sensitive liquid chromatography coupled with tandem mass spectrometry (MS/MS) method was developed and validated for the quantitation of the novel CDK5 inhibitor ‘20–223' in mouse plasma. Separation of analytes was achieved by a reverse-phase ACE Excel C₁₈ column (1.7 μm, 100 × 2.1 mm) with gradient elution using 0.1% formic acid (FA) in methanol and 0.1% FA as the mobile phase. Analytes were monitored by MS/MS with an electrospray ionization source in the positive multiple reaction monitoring mode. The MS/MS response was linear over the concentration range 0.2–500 ng/mL for 20–223. The within- and between-batch precision were within the acceptable limits as per Food and Drug Administration guidelines. The validated method was successfully applied to plasma protein binding and in vitro metabolism studies. Compound 20–223 was highly bound to mouse plasma proteins (>98% bound). Utilizing mouse S9 fractions, in vitro intrinsic clearance (CL_int) was 24.68 ± 0.99 μL/min/mg protein. A total of 12 phase I and II metabolites were identified with hydroxylation found to be the major metabolic pathway. The validate method required a low sample volume, was linear from 0.2 to 500 ng/mL, and had acceptable accuracy and precision.     

Propylphosphonic anhydride(T3P~) catalyzed one-pot synthesis of α-aminonitriles

The Strecker reaction was performed via a one-pot three component condensation of hetero aromatic/aromatic aldehydes, secondary amines and trimetylsilyl cyanide in the presence of propylphosphonic anhydride(T3P~) to accomplish the corresponding a-aminonitriles. The main advantages of this method are very short reaction time and excellent yields.     

煤直接液化油中混合酚的分离研究

利用分子筛择形特点，对煤直接液化油中的混合酚实施高效分离。本研究选取间甲酚和对甲酚作为分离煤直接液化油馏分段混合酚的模型化合物，采用化学液相沉积法对HZSM-5吸附剂的孔口结构进行改变，分析分子筛硅铝比及颗粒粒径对模型化合物间甲酚和对甲酚吸附分离性能的影响，以获得高性能固相吸附剂，并将其应用于180-190℃馏分段混合酚分离。结果表明，当分子筛硅铝比为25、粒径为3-5 μm时，分子筛的孔口结构调节效果最优；当正硅酸乙酯的最小用量为0.2 mL/g时，固相吸附剂的吸附量为0.03 g/g，对甲酚选择性高于95%。由于外表面沉积物对吸附剂的孔口结构变化，导致对甲酚选择性的提高。进一步采用HZSM-5（1）吸附剂对真实煤直接液化油混合酚的分离中发现，苯酚和对甲酚的选择性均达到100%。     

基于5-磺基水杨酸的单、双核铜(Ⅱ)三元混配配合物的合成及晶体结构

以5-磺基水杨酸和咪唑衍生物为配体合成了单核、双核结构的三元混配Cu(Ⅱ)配合物:[Cu(H₂biim)(Hssal)(H₂O)₂]·H₂O(1)和{[Cu(MeHbiim)(Hssal)(H₂O)]·0.5H₂O}₂(2)(H₃ssal=5-磺基水杨酸,H₂biim=2,2’-联咪唑,MeHbiim=N-甲基-2,2’-联咪唑),并利用元素分析、红外光谱、紫外-可见光谱、X-射线单晶衍射及热重分析等技术手段对其结构进行了表征。单晶结构解析表明配合物1属于单斜晶系,P2₁／C 空间群,Cu(Ⅱ)离子与1个5-磺基水杨酸根、2个水分子以及1个联咪唑分子形成五配位四角锥构型的单核配合物结构。配合物2属于正交晶系,P2(1)2(1)2(1)空间群,双核Cu(II)离子分别处于五配位四角锥和四配位平面四边形的几何构型的配位环境中,与配合物1不同,5-磺基水杨酸采取μ₂双-单齿配位模式。荧光光谱分析表明配合物2具有较强的荧光性。     

Investigating the kinetics of liquid-free,OSDA-free ZSM-5 zeolite synthesis from iron ore tailings

In this study, ZSM-5, which is a Mobil-type five-type zeolite with well-defined crystal morphology, is successfully synthesized via a seed-assisted, liquid-free method that uses iron ore tailings as a silica source. The ZSM-5 crystallization kinetics at 423, 433, and 443 K and different synthesis times are investigated to identify the nucleation and crystallization mechanisms of the synthesized ZSM-5 zeolites, and results suggest that the crystallization kinetics follow a Kolmogorov-Johnson-Mehl-Avrami-type behavior. The activation energies for the induction and transition periods are 112.38 and 58.35 kJ mol⁻¹, respectively. Furthermore, the Avrami exponent indicates three-dimensional crystal growth from both sporadic and instantaneous nucleation mechanisms. A comparison of our results with previous reports of the ZSM-5 crystallization mechanism demonstrates that the seed crystals play a significant role in nucleation and crystal growth. Finally, seed surface crystallization and new nuclei crystallization dual mechanism has been proposed to describe the crystallization process of ZSM-5.     

Experimental and theoretical studies of Mn(II) and Co(II) metal complexes of a tridentate Schiff's base ligand and their biological activities

We have used the condensation method to synthesize 2-acetyl-5-methylsemicarbazone ligand. Manganese(II) and Cobalt(II) complexes having formula [ML₂]X₂ were synthesized where M = Mn(II) and Co(II), L = ligand, X = Cl⁻, CH₃COO⁻, NO₃⁻, ½SO₄²⁻. The characterization data suggests the octahedral geometry for all the synthesized complexes. Tridentate nature of the 2-acetyl-5-methylsemicarbazone ligand was revealed by IR studies. Molar conductance analysis suggested the electrolytic nature of the complexes. The theoretical study includes geometrical optimization, HOMO-LUMO energy gap, energetic parameters and dipole moment. These results also confirmed the tridentate nature of the ligand and the octahedral geometry of complexes. The molecular electrostatic potential (MEP) study suggested the reactive sites for an electrophilic or nucleophilic attack in the ligand. We tested the synthesized compounds for their antifungal and antibacterial action via well diffusion method and found that parent ligand after the coordination with the metal ion showed more effective inhibition against bacteria and fungi.     

Design and synthesis of the honeycomb PtSnNa/ZSM-5 monolithic catalyst for propane dehydrogenation

A novel PtSnNa/ZSM-5 monolithic catalyst was designed and synthesized for the propane dehydrogenation reaction, which was a significant transformation in industry. Experimental results showed that although the propane conversion and the propylene selectivity gradually fell down along with the reaction time, the descent speed of the PtSnNa/ZSM-5 monolithic catalyst was slower than that of the granule catalyst and the propane conversion and propylene selectivity of the reaction with monolithic catalyst still remained at a high level after 12 hr. The monolithic catalyst had regular pore structure that facilitated the separation of the product from the catalyst and reduced the limitation on internal and external diffusion and mass transfer, and led to the high catalytic activity and stability. The catalyst could be easily fabricated and was of highly industrial application potential.